Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash & Current Investments: 2009-2012

Historic Cash & Current Investments for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $206.8 million.

  • Lexicon Pharmaceuticals' Cash & Current Investments rose 43.49% to $206.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $973.7 million, marking a year-over-year increase of 37.34%. This contributed to the annual value of $281.7 million for FY2011, which is 33.43% up from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Cash & Current Investments of $206.8 million as of Q3 2012, which was down 10.65% from $231.5 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' Cash & Current Investments' 5-year high stood at $314.2 million during Q1 2010, with a 5-year trough of $25.9 million in Q1 2009.
  • In the last 3 years, Lexicon Pharmaceuticals' Cash & Current Investments had a median value of $231.0 million in 2010 and averaged $227.2 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first surged by 1,112.21% in 2010, then crashed by 39.87% in 2011.
  • Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Cash & Current Investments stood at $157.1 million in 2009, then spiked by 34.38% to $211.1 million in 2010, then soared by 33.43% to $281.7 million in 2011, then spiked by 43.49% to $206.8 million in 2012.
  • Its Cash & Current Investments stands at $206.8 million for Q3 2012, versus $231.5 million for Q2 2012 and $253.7 million for Q1 2012.